Aerovate Therapeutics Inc (AVTE) — Financial Flexibility Index
Aerovate Therapeutics Inc (AVTE) has a Financial Flexibility Index of -0.96x as of March 2025. Free cash flow of $-2.38 Million (operating CF $-2.38 Million minus capex $0.00) represents -1% of total liabilities ($2.49 Million). Also explore net asset growth rate of Aerovate Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aerovate Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Aerovate Therapeutics Inc across 6 annual periods. Check Aerovate Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aerovate Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Aerovate Therapeutics Inc. For the full company profile including market capitalisation, see Aerovate Therapeutics Inc (AVTE) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -18.26x | $-71.20 Million | $-71.20 Million | $3.90 Million | ▼ -479.3% |
| 2023 | -3.15x | $-56.64 Million | $-56.78 Million | $17.96 Million | ▲ +30.7% |
| 2022 | -4.55x | $-38.93 Million | $-39.12 Million | $8.56 Million | ▲ +50.8% |
| 2021 | -9.24x | $-27.22 Million | $-27.40 Million | $2.94 Million | ▼ -2073.8% |
| 2020 | -0.43x | $-7.68 Million | $-7.86 Million | $18.06 Million | ▼ -17.0% |
| 2019 | -0.36x | $-2.60 Million | $-2.78 Million | $7.16 Million | — |